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Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer’s
disease. A fundamental tenet of the amyloid hypothesis of Alzheimer’s disease is that the
deposition of amyloid-β precedes and induces the neuronal abnormalities that underlie dementia1.
This idea has been challenged, however, by the suggestion that alterations in axonal trafficking
and morphological abnormalities precede and lead to senile plaques2. The role of microglia in
accelerating or retarding these processes has been uncertain. To investigate the temporal relation
between plaque formation and the changes in local neuritic architecture, we used longitudinal in
vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP)
transgenic mice3. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1–2
days of a new plaque’s appearance, microglia are activated and recruited to the site. Progressive
neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks.
These data establish plaques as a critical mediator of neuritic pathology.
To explore the formation of amyloid plaques and to determine the effects of newly formed
dense-cored plaques on the microarchitecture of the brain, we have developed a novel in
vivo multiphoton imaging technique. This recognizes newly formed plaques and allows
monitoring of their immediate vicinity thereafter to determine the rate of their formation and
the temporal sequence of pathophysiological events. We imaged young (5- to 6-month-old)
B6C3-YFP mice, an age when plaques begin to appear4 (Fig. 1). We used three-colour
imaging to establish fiduciary markers for repeated imaging: YFP positive neurons,
dendrites and axons in the cortex, methoxy-XO4-labelled fibrillar amyloid-β deposits in the
parenchyma and on vessel walls, and a fluorescent angiogram with Texas red dextran to
image blood vessels. A volume of cortex (lamina I–III) that initially did not contain plaques
was re-imaged until repeat imaging detected a new plaque, establishing its ‘birthday’. To
ensure that the appearance of a new plaque did not simply reflect a greater depth of imaging
or a slightly different imaging volume, we went through each image stack and compared
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them with previous sessions. New plaques were accepted only if a uniquely identifiable
fiduciary point, such as a blood vessel or a dendritic process, could be unambiguously noted
in a deeper imaging plane.
We postulated that we would occasionally observe the appearance and growth of new
plaques within an imaging volume if the time interval between imaging sessions was long
enough. From one weekly imaging session to the next, most of the sites remained unchanged
(Supplementary Fig. 1a–c). However, we identified 14 new plaques: instances in which a
plaque appeared in a second imaging session in a volume that had clearly been unoccupied
in the first images one week earlier (Fig. 1a–c).
We examined the spatial relation between newly identified plaques and blood vessels.
Measurements of the distance between vessel wall and the edge of a plaque confirmed that
dense-core plaques develop close to but not within blood vessels (9.1 ± 3.9 µm from blood
vessels). As a control, 70 randomly placed, plaque-sized objects had an average distance of
8.4±11.2 µm from a vessel. New plaques therefore do not form any closer to vessels than
would be expected by chance, in accord with an earlier study of human Alzheimer’s
disease 5. Furthermore, multiphoton microscopic images showed that newly formed plaques
were not penetrated by blood vessels6, suggesting only a limited direct role of blood vessels
in the formation of dense-core plaques.
To examine whether the phenotype of plaque formation in as short a period as one week was
unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a
slower progression of disease (Tg2576)7. Seven Tg2576 transgenic mice (11 months) were
imaged weekly, and fourteen additional new plaques were observed, suggesting that the
rapid plaque formation is not restricted to one mouse model (Supplementary Fig. 2).
We next imaged the B6C3-YFP mice on a daily basis for up to six days in a row and/or on a
weekly basis for up to three weeks (Fig. 1d–i). To our surprise, senile plaque formation is a
very rapid event, with five new plaques appearing precipitously within 24 h after the last
imaging session. However, plaque formation is a rare event. Combining our experiments of
daily and weekly imaging, a total of 26 new plaques were found in 14 animals over 238
sites, imaged a total of 1,285 times.
These newly formed plaques were then re-imaged over days to weeks to determine their
growth pattern. Measurements of plaque area over several imaging sessions revealed that
they do not change in size after about the first 24 h, regardless of whether they had small or
large diameters when they were first imaged (Fig. 1j). To examine whether imaging
procedures had affected the observed plaque characteristics, we compared in vivo measures
with those obtained from post-mortem analysis of mice either after our imaging protocols or
with naive mice that had never been imaged. These analyses confirmed that the newly
formed plaques are not significantly different in area or diameter from those observed post
mortem and therefore represent typical plaques (Supplementary Fig. 3). Furthermore, the
size distribution of new plaques compares well with that of all plaques seen post mortem in
non-imaged mice (Supplementary Fig. 3). The shape of this histogram is also quite similar
to that observed in analyses of human patients with Alzheimer’s disease8.
Several studies have shown that microglia surround senile plaques both in patients with
Alzheimer’s disease and transgenic mouse models 9,10 although their role remains
elusive11,12. It has been proposed that activated microglia clear amyloid deposits13, are the
nidus for initiation of amyloid fibrils14 or restrict plaques15. To study the interaction
between newly formed amyloid plaques and microglia, we imaged microglia before and
after plaque formation (Fig. 2) in PDAPP mice crossed with a line that expresses enhanced
green fluorescent protein (EGFP) in microglia16,17. In this third APP transgenic line, we
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again found rapid formation of new plaques, with seven new plaques occurring within 24 h.
Microglia were attracted to the site of plaque formation within a day (Fig. 2b). None of the
new plaques occurred immediately adjacent to resident microglia, suggesting that microglia
do not form the nidus of new plaques. We did not observe any plaques being cleared by this
microglial response. This suggests that, unless further activated18, microglia do not
successfully clear plaques but instead may well restrict their growth, leading to the observed
steady state of plaque size after initial formation.
Stokin et al. recently proposed that amyloid deposits followed axonal trafficking defects,
marked morphologically as neuritic dystrophies. In contrast, amyloid deposition has been
postulated to cause neuronal alterations1,19. To study the temporal relation between newly
formed plaques and dystrophic neurites, we compared the shape and trajectories of yellow
fluorescent protein (YFP) fluorescent neurites before and after plaque formation in B6C3-
YFP animals (Fig. 3). These neurites were morphologically normal in the volume of cortex
one day before plaque formation. By contrast, in the days after plaque formation,
progressive neuritic alterations were evident: from a smooth bend around the new plaque to
very tortuous changes identical in appearance to dystrophic neurites seen in Alzheimer’s
disease20. The degree of neuritic deformation is best illustrated in individual image slices
(Fig. 3a, c) as well as in three-dimensional reconstructions (Fig. 3b, d).
Neurite curvature was quantitatively analysed20,21 from the in vivo images around each new
plaque (n = 12) as well as more than 50 µm away from it, and compared with equivalent
measures in randomly selected fields from YFP control mice. As expected, neurites were
essentially straight, and unchanged in morphology over several weeks of imaging in YFP
mice. In the B6C3-YFP mice, in the immediate vicinity of plaques the tortuosity increased
gradually over the first week (Fig. 3e, P < 0.0001). Post-mortem analysis of neuritic
curvature (n = 218) taken of randomly selected plaques observed at the time of death
confirmed that neuritic curvature measured around new plaques one week after their
formation is indistinguishable from the same measurements taken around all plaques
(1.048±0.02 versus 1.052±0.014). This suggests that neuritic changes occur rapidly and to
essentially a maximal extent over the first week of a plaque’s presence.
We next analysed changes in neurites near plaques on a daily basis. No change from
baseline in neuritic curvature was detected on the day of plaque appearance (Fig. 3f).
Neuritic alterations were first evident one day after the occurrence of a new plaque,
indicating that neuritic deformation is a secondary effect of plaque development (n = 15;
analysis of variance (ANOVA P = 0.02)). After two days the damage became more
prominent; after five days it resembled the more robust neuritic damage seen after one week
(Fig. 3e, f). Thus the neurite changes progressed over days after a short lag phase (although
the imaging would not detect more subtle changes in cytoskeleton that might occur even
earlier). In several instances, frank neuritic dystrophies appeared on a previously normal
dendrite three to four days after the first appearance of a new senile plaque (Fig. 1). In
almost all instances of new plaque formation (11 of 13 new plaques in which concurrent
observation of YFP filled neurites was obtained), frank neuritic dystrophies followed plaque
formation within one week (Supplementary Fig. 4a, b) (χ2 test P < 0.001). Post-mortem
immunostaining suggested that both dendritic and axonal elements contribute to these
dystrophic neurites (Supplementary Fig. 5).
Axonal dystrophies can be observed both near plaques and in the neuropil without a plaque.
Such dystrophies have been hypothesized to anticipate the location of plaques2. We tested
the idea that areas with a high density of dystrophies would be a prime location for plaque
development. We tracked sites containing dystrophies but no plaques over days to weeks,
but never observed a new plaque appearing at a site of high dystrophic neurite density.
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Instead, it seemed that these dystrophic processes are quite dynamic. Out of ten examples,
40% of the dystrophic neurites changed morphologies (with some even resolving
completely) and only 60% were unaltered over one to two weeks of imaging
(Supplementary Fig. 4c–f).
Because our in vivo amyloid imaging agent, methoxy-XO4, would not report amyloid-β
deposits that do not contain β-pleated sheets, we compared immunostaining for amyloid-β
and methoxy-XO4 in histologic specimens to look for diffuse plaques in 8-month-old B6C3-
YFP mice. All of the plaques were dense-core in morphology, with co-staining of amyloid-β
immunofluorescence and methoxy-XO4 (Supplementary Fig. 6). Because these mice
develop innumerable plaques, the absence of any plaques with a diffuse morphology argues
against the idea that dense-core plaques represent a remodelled form of diffuse, ‘primitive’
plaques.
Longitudinal in vivo imaging of plaque formation provides a new appreciation for the
kinetics of the amyloid deposition process in vivo, and demonstrates the temporal relations
between amyloid deposits, microglial recruitment and activation, and neuritic changes.
Although it takes months for many plaques to accumulate, even in accelerated mouse
models of Alzheimer’s disease7,16, our data show that an individual dense-core plaque’s
formation unexpectedly represents an acute event. These results are surprising because it has
been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β
aggregation is time dependent and follows a relatively slow nucleation-dependent
polymerization process22. It is possible that submicroscopic nuclei may be present in the
cortex23, perhaps related to the recently reported amyloid-β oligomeric forms24,25, as
precursors to this sudden growth.
Observing the ‘birthday’ of new plaques provides the opportunity to examine directly
whether dystrophic neurites near amyloid deposits precede or follow amyloid deposition.
Our data strongly argue in favour of the latter, and suggest a period of several days after
plaque formation during which progressive cytoskeletal derangements occur in neurites near
a plaque. The observation of a local microenvironment in which microglia are recruited and
activated after plaque formation further supports a model in which plaques act as a reservoir
of bioactive molecules (Supplementary Fig. 7), which subsequently lead to neuronal
alterations19 including local loss of dendritic spines and axonal dystrophies26. These data
thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid
deposition, activation and recruitment of microglia and local neuritic changes play out as a
sequential cascade leading to neurodegeneration1.
The current observations provide narrow parameters on the kinetics of plaque growth and
stabilization through microglia, and raise the possibility that the years-long degenerative
process of Alzheimer’s disease is marked by innumerable sudden changes in cortical
structure. Altering the kinetics of this process may well change the rate of progression of
Alzheimer’s disease.
METHODS SUMMARY
Three different APP transgenic mouse lines were used in this study (B6C3-YFP, Tg2576
and PDAPP+/−xCX3CR1-GFP+/−). Cranial window surgery was performed followed by
either daily or weekly in vivo multiphoton microscopy26. After completion of in vivo
imaging, frozen brain sections were stained immunohistochemically. Image analysis
measuring plaque size or neuritic curvature was done using Image J (National Institutes of
Health freeware).
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Full Methods and any associated references are available in the online version of the paper
at www.nature.com/nature.
METHODS
Animals and surgical procedures
APPswe/PS1d9xYFP (B6C3-YFP; obtained from Jackson Laboratory, Bar Harbor, Maine)
and Tg25767 transgenic mice were used in this study; YFP transgenic mice served as
controls (a total of six double transgenic, five transgenic and four littermate controls
expressing only the YFP transgene were followed through three to eight weekly and one to
six daily imaging sessions)4. B6C3-YFP mice overexpress YFP in a subset of cortical
neurons, and start to develop plaques in the neocortex between five and seven months of
age. In addition, homozygous PDAPP mice16 were crossed with homozygous CX3CR1-GFP
mice17, and two female PDAPP+/−×CX3CR1-GFP+/− transgenic mice at the age of 18
months were used in this study and imaged for three consecutive days. All animal work
conformed to National Institutes of Health and institutional guidelines. Cranial window
surgery was done under isoflurane anaesthesia by installing a glass window 6 mm in
diameter on top of the brain. One day before surgical procedure, mice received an
intraperitoneal injection of methoxy-XO4 (5 mg kg−1), a fluorescent compound that crosses
the blood–brain barrier and binds to amyloid plaques27.
Multiphoton imaging
In vivo imaging of amyloid pathology, YFP-positive neuronal processes and blood vessels in
the living mouse brain was performed on a Bio-Rad 1024ES multiphoton microscope (Bio-
Rad Laboratories), mounted on an Olympus BX50WI upright microscope (Olympus
Optical). Texas red dextran (molecular mass 70,000 daltons, 12.5 mg/ml in sterile
phosphate-buffered saline (Molecular Probes)) was injected into the lateral tail vein and
served as a guide to repeatedly find the same sites in the brain by providing a fluorescent
angiogram. A wax ring was placed around the coverslip of the cortical window and filled
with distilled water to create a well for an Olympus 20X dipping objective (numerical
aperture 0.95). A mode-locked Ti:Sapphire laser (MaiTai, Spectra-Physics) generated two-
photon fluorescence with 800 nm excitation, and detectors containing three photomultiplier
tubes (Hamamatsu Photonics) collected emitted light in the range of 380–480, 500–540 and
560–650 nm. During each imaging session, images at low resolution (615 µm × 615 µm × 5
µm sections; 10–20 sections per stack) were captured to provide an overview of the area,
followed by images with high resolution (approximately 150 µm × 150 µm × 1 µm sections;
15–50 sections per stack) to zoom in on a specific area. Observations of the same neurites
and plaques over time were made using the four-dimensional stack acquisition feature
within imaging sessions and by taking images of the same neurites and plaques in
subsequent weekly imaging sessions.
At the end of imaging sessions, mice were allowed to recover on a heating pad and placed
singly in their home cage. For subsequent weekly or daily imaging sessions, mice were
again injected with methoxy-XO4 the day before imaging, then anaesthetized, injected with
Texas red dextran intravenously, and observed under the multi-photon microscope as
described above. After the last imaging session, mice were euthanized with an overdose of
avertin (400 mg kg−1) and the brains immersion-fixed in 4% paraformaldehyde in phosphate
buffer with 15% glycerol cryoprotectant.
Image processing and data analysis
To exclude motion artefacts induced by heartbeat and breathing, image stacks were aligned
using AutoDeblur software (AutoQuant). Two-dimensional projections of stacks from each
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of the three channels were combined in Adobe Photoshop 7 (Adobe Systems).
Reconstructions of neurites, plaques and amyloid angiopathy in three dimensions were
performed by reconstructing software from synapse web at the Medical College of Georgia
(www.synapses.mcg.edu).
Plaque size (area in square micrometres) of the new plaques was assessed along with the
distance from each plaque edge to the nearest blood vessel. In images from non-transgenic
control animals, acquired with fluorescent angiograms, simulations were performed by
randomly placing two phantom plaques with the average new plaques to measure the
distances of the plaque edge to the nearest blood vessels. The coordinates of the phantom
plaques were determined by generating random numbers from 0 to 512. Data were
expressed as mean±standard deviation from the mean.
Quantitative measurements were performed in Image J (National Institutes of Health
freeware). The distance of neurites from the nearest plaque (if present) was determined as
the average of the distance measured from each end and the midpoint of the neurite segment
to the edge of the plaque. Neurite curvature ratios were calculated by dividing the total
length of a neurite by the end-to-end distance of a neurite segment20,26. Dystrophic neurites
with swellings greater than 2.5 µm were classified as dystrophic and included in the study.
Data were expressed as mean ± standard deviation from the mean. Group means were
compared by ANOVA in the StatView program (SAS Institute, Inc.). The level of
significance was set at P ≤ 0.05.
Immunohistochemistry
The brains were frozen and serial coronal sections 25 µm thick were cut on a freezing
sliding microtome. Sections were immunostained with the monoclonal primary antibodies
3D6 (Elan Pharmaceuticals), Smi312 (Covance Research Products, Inc.), Smi32
(Sternberger Monoclonals), synaptophysin (Abcam) followed by secondary anti-mouse
conjugated cyanine 3 (Cy3) (Jackson ImmunoResearch). Additionally, three brains of 8-
month-old B6C3 mice were cut in coronal sections 45 µm thick and stained post mortem
with methoxy-XO4. Images were acquired either with an upright Olympus Optical BX51
fluorescence microscope with an Olympus Optical DP70 camera or with a Zeiss LSM510
Meta confocal microscope and analysed using Image J (National Institutes of Health
freeware) and Adobe Photoshop 7 (Adobe Systems). The mean area of plaque size post
mortem was determined by using Bioquant image analysis software.
Supplementary Material
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Figure 1. Appearance of a novel plaque is a rapid process
a–c, Low-magnification images provide an overview of the areas of potential plaque
formation. The angiogram (red, Texas red), amyloid deposition (blue, methoxy-XO4) and
neurons (green, YFP) are easily identified on the initial day of surgery (a) as well as one
week (b) and two weeks later (c), allowing reimaging of the same sites over different
imaging sessions. A new parenchymal amyloid deposition was identified one week (b) and
two weeks (c) after the first imaging at this site. The new plaque appearing is indicated by
an arrow (b and c). d–i, Sequential daily imaging of a potential plaque-formation area
revealed that plaques can form rapidly in a short time interval from one day to another (e).
The initial plaque was joined by a novel plaque marked with arrows over six consecutive
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days (e–i). Note the formation of a dystrophy indicated by an arrowhead (i). A line diagram
was used in this figure to visualize plaque size over time. The mean area of new plaques was
88.7 ± 69.3 µm2 (mean ± s.d.) (n = 18). This is comparable to the mean plaque area of 93.7
± 74.8 µm2 (mean ± s.d.) (n = 153) (Student’s t-test not significant, P = 0.77) measured post
mortem in a subset of these animals by using the Bioquant image analysis system. Each
individual plaque that appeared either after one day or seven days is represented by a
different colour (j). Scale bars, 30 µm (a–c) and 20 µm (d–i).
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Figure 2. Microglia recruitment follows plaque formation
a–f, Green fluorescent protein-positive microglia cells were imaged in
PDAPP+/−CX3CR1+/− mice before and after plaque formation in daily imaging sessions. b,
e, Two plaques appeared within 24 h (arrows) as well as microglia around these newly
formed plaques. Individual microglia remained stable but new microglia surrounding
plaques were also evident (arrowhead). Scale bars, 20 µm.
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Figure 3. Plaque formation has no immediate effect on neuritic curvature
a–d, Neurites were observed before and after plaque formation. A new plaque labelled with
methoxy-XO4 is shown in c and indicated by an arrow. Images from the green channel were
further analysed and neurite curvature was measured. Arrowheads in c and d denote the
increased neurite curvature after a plaque formed. Three-dimensional reconstruction as an
example of a developed plaque (blue) surrounded by deforming neurites (green) (b, d).
Scale bar, 50 µm. e, Neurite curvature was measured one week before and after plaque
development. Neurites (n = 29) measured in B6C3-YFP mice (n = 6) less than 50 µm from a
plaque, neurites more than 50 µm from a plaque (n = 27) and neurites (n = 40) in control
mice (n = 5) are depicted as black, grey and white bars, respectively. There was a
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statistically significant increase in neurite curvature after plaques form compared with the
initial imaging session one week earlier. This increase persists one week after formation
(two weeks from initial time point) (asterisk, ANOVA P < 0.0001). f, Daily assessment of
neurite curvature changes (n = 12) from five new plaques revealed no significant differences
at the day of plaque occurrence (data from all new plaques normalized to show plaque
appearance at day 2). However, there was a tendency towards increased curvature, which
became statistically significant at the third imaging day, one day after plaque appearance
(asterisk, ANOVA P = 0.002). At imaging day 6, the neurite curvature ratio reached the
highest level (asterisk, ANOVA P = 0.0002) and was comparable to that seen one week after
plaque formation (day 7). Data are shown as mean ± standard deviation.
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